Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia

This study has been completed.

Sponsor:

Collaborator:

Information provided by:

Roswell Park Cancer Institute

ClinicalTrials.gov Identifier:

NCT00053144

First received: January 27, 2003

Last updated: March 7, 2011

Last verified: March 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2003
Primary Completion Date:	February 2003 (Final data collection date for primary outcome measure)